American Shared Hospital Services (AMS) Q3 2024 Earnings Call Transcript Summary
American Shared Hospital Services (AMS) Q3 2024 Earnings Call Transcript Summary
Gross margin declined by $732,000 due to lower Gamma Knife treatment volumes and changes in business mix.The following is a summary of the American Shared Hospital Services (AMS) Q3 2024 Earnings Call Transcript:
以下是american shared hospital services (AMS) 2024年第三季度業績會記錄的摘要：
Financial Performance:
財務業績：
AMS reported Q3 2024 revenue of $6.99 million, up 36% year-over-year from $5.1 million in Q3 2023.
The company experienced a net loss of $207,000 or $0.03 per share, compared to a net gain of $118,000 or $0.02 per share in the same quarter the previous year.
Gross margin declined by $732,000 due to lower Gamma Knife treatment volumes and changes in business mix.
AMS報告2024年第三季度營業收入爲$699萬，同比2023年第三季度的$510萬增長了36%。
該公司出現淨虧損$207,000，或每股$0.03，而去年同期爲淨收益$118,000或每股$0.02。
毛利率因Gamma Knife治療成交量下降和業務組合變化而減少了$732,000。
Business Progress:
業務進展：
AMS announced the addition of Gary Deans as Executive Vice President and Chief Operating Officer, and the promotion of Ranjit Pradhan to Senior Vice President, Sales and Marketing.
The company continues its international expansion with the opening of a new facility in Puebla, Mexico and a joint venture for a Gamma Knife facility in Guadalajara, Mexico.
AMS has started implementing cost efficiencies, particularly following the Rhode Island acquisition, to optimize operations and improve patient care.
AMS宣佈Gary Deans加入擔任執行副總裁兼首席運營官，並將Ranjit Pradhan晉升爲銷售與市場高級副總裁。
該公司在國際擴張方面持續努力，在墨西哥普埃布拉開設新設施，並與墨西哥瓜達拉哈拉合作成立Gamma Knife設施的創業公司。
AMS已開始實施成本效率，特別是在羅德島收購後，以優化運營並改善患者護理。
Opportunities:
機會：
AMS is poised for growth with the recent Rhode Island acquisition, adding three new revenue streams.
Further international expansion is expected to strengthen the company's position, with new centers in Guadalajara and Puebla already operational.
AMS憑藉最近的羅德島收購，準備迎接增長，新增三條營業收入來源。
預計進一步的國際擴張將增強公司的地位，位於瓜達拉哈拉和普埃布拉的新中心已開始運營。
Risks:
風險：
Seasonality and procedure volume fluctuations are ongoing challenges in maintaining steady revenues.
The integration of newly acquired facilities and upgrading of equipment require significant investment and may temporarily impact profitability.
季節性和手術量波動是保持穩定營業收入的持續挑戰。
新收購設施的整合和設備的升級需要大量投資，可能暫時影響盈利能力。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。
